JP2022007994A5 - - Google Patents

Download PDF

Info

Publication number
JP2022007994A5
JP2022007994A5 JP2021033150A JP2021033150A JP2022007994A5 JP 2022007994 A5 JP2022007994 A5 JP 2022007994A5 JP 2021033150 A JP2021033150 A JP 2021033150A JP 2021033150 A JP2021033150 A JP 2021033150A JP 2022007994 A5 JP2022007994 A5 JP 2022007994A5
Authority
JP
Japan
Prior art keywords
pharmaceutically acceptable
acceptable salt
optionally substituted
alkyl
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021033150A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022007994A (ja
JP7739012B2 (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2022007994A publication Critical patent/JP2022007994A/ja
Publication of JP2022007994A5 publication Critical patent/JP2022007994A5/ja
Priority to JP2025145992A priority Critical patent/JP2025175000A/ja
Application granted granted Critical
Publication of JP7739012B2 publication Critical patent/JP7739012B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021033150A 2020-03-04 2021-03-03 縮合三環性化合物及びその医薬用途 Active JP7739012B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025145992A JP2025175000A (ja) 2020-03-04 2025-09-03 縮合三環性化合物及びその医薬用途

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2020036931 2020-03-04
JP2020036931 2020-03-04
JP2021001452 2021-01-07
JP2021001452 2021-01-07

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025145992A Division JP2025175000A (ja) 2020-03-04 2025-09-03 縮合三環性化合物及びその医薬用途

Publications (3)

Publication Number Publication Date
JP2022007994A JP2022007994A (ja) 2022-01-13
JP2022007994A5 true JP2022007994A5 (https=) 2024-03-05
JP7739012B2 JP7739012B2 (ja) 2025-09-16

Family

ID=77613417

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021033150A Active JP7739012B2 (ja) 2020-03-04 2021-03-03 縮合三環性化合物及びその医薬用途
JP2025145992A Withdrawn JP2025175000A (ja) 2020-03-04 2025-09-03 縮合三環性化合物及びその医薬用途

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025145992A Withdrawn JP2025175000A (ja) 2020-03-04 2025-09-03 縮合三環性化合物及びその医薬用途

Country Status (27)

Country Link
US (1) US20230025880A1 (https=)
EP (2) EP4116301B1 (https=)
JP (2) JP7739012B2 (https=)
KR (1) KR20220149688A (https=)
CN (1) CN115151543B (https=)
AU (1) AU2021230880A1 (https=)
BR (1) BR112022014749A2 (https=)
CA (1) CA3166747A1 (https=)
CL (1) CL2022002355A1 (https=)
CO (1) CO2022012548A2 (https=)
DK (1) DK4116301T3 (https=)
ES (1) ES3052010T3 (https=)
FI (1) FI4116301T3 (https=)
HR (1) HRP20251364T1 (https=)
IL (1) IL295836B2 (https=)
LT (1) LT4116301T (https=)
MX (1) MX2022010950A (https=)
PE (1) PE20221908A1 (https=)
PH (1) PH12022552259A1 (https=)
PL (1) PL4116301T3 (https=)
PT (1) PT4116301T (https=)
RS (1) RS67408B1 (https=)
SI (1) SI4116301T1 (https=)
SM (1) SMT202500464T1 (https=)
TW (1) TWI884224B (https=)
WO (1) WO2021177330A1 (https=)
ZA (1) ZA202209620B (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10800784B2 (en) * 2018-02-01 2020-10-13 Japan Tobacco Inc. Nitrogen-containing heterocyclic amide compound and pharmaceutical use thereof
PL4116301T3 (pl) * 2020-03-04 2026-02-16 Japan Tobacco Inc. Skondensowany związek tricykliczny i jego zastosowanie medyczne
CN117897382A (zh) * 2021-09-01 2024-04-16 日本烟草产业株式会社 含氮三环化合物及其药物用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602004025220D1 (de) * 2003-04-11 2010-03-11 High Point Pharmaceuticals Llc Pharmazeutische verwendungen von kondensierten 1,2,4-triazolen
US20050085531A1 (en) * 2003-10-03 2005-04-21 Hodge Carl N. Thiophene-based compounds exhibiting ATP-utilizing enzyme inhibitory activity, and compositions, and uses thereof
KR100808551B1 (ko) * 2006-12-01 2008-03-03 한국생명공학연구원 트리아졸 유도체를 유효성분으로 함유하는 대사성 질환 예방 및 치료용 약학적 조성물
MY182884A (en) * 2013-03-15 2021-02-05 Japan Tobacco Inc Pyrazole-amide compound and medicinal uses therefor
CA2994027C (en) * 2015-07-31 2023-10-10 Merck Patent Gmbh Bicyclic heterocyclic derivatives
US10800784B2 (en) * 2018-02-01 2020-10-13 Japan Tobacco Inc. Nitrogen-containing heterocyclic amide compound and pharmaceutical use thereof
US20220362215A1 (en) 2018-09-11 2022-11-17 Japan Tobacco Inc. Therapeutic or prophylactic agent for chronic kidney disease containing pyrazole-amide compound
PL4116301T3 (pl) 2020-03-04 2026-02-16 Japan Tobacco Inc. Skondensowany związek tricykliczny i jego zastosowanie medyczne

Similar Documents

Publication Publication Date Title
JP2022007994A5 (https=)
JP2015524443A5 (https=)
JP2019131544A5 (https=)
JP2014521700A5 (https=)
JP2021516240A5 (https=)
JP5298129B2 (ja) 可溶性グアニレートシクラーゼ活性化因子
SILVERSTEIN et al. Avoiding the hemodynamic consequences of aortic cross-clamping and unclamping
KR101615399B1 (ko) 리바록사반 및 말론산의 신규 공결정 화합물
JP2019518036A5 (https=)
JP2015533168A5 (https=)
JP2019527215A5 (https=)
HRP20161378T1 (hr) Dihidropiridon kao faktor xia inhibitora
HRP20251364T1 (hr) Kondenzirani triciklički spoj i njegova medicinska upotreba
JP2019521111A5 (https=)
JP2019518041A5 (https=)
JP2016517432A5 (https=)
JP2004521095A5 (https=)
JP2019521153A5 (https=)
JPWO2023032940A5 (https=)
JP2008543972A5 (https=)
CN103270024A (zh) 新的取代异喹啉衍生物
RU2015137972A (ru) Новые производные дигидрохинолин-2-она в качестве ингибиторов альдостеронсинтазы (cyp1 1 b2 или cyp1 1 b1)
JP2019507167A5 (https=)
JP2008517954A (ja) 抗血小板剤としての置換ピリドキシン
JP2007506679A5 (https=)